Discontinuation report DELATESTRYL
| Report ID | 221772 |
| Drug Identification Number | 00029246 |
| Brand name | DELATESTRYL |
| Common or Proper name | DELATESTRYL |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | TESTOSTERONE ENANTHATE |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 5ml |
| ATC code | G03BA |
| ATC description | ANDROGENS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2024-05-15 |
| Actual discontinuation date | 2024-04-25 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | 3rd party manufacturer will no longer supply |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-26 | English | Compare |
| v4 | 2024-04-25 | French | Compare |
| v3 | 2024-04-25 | English | Compare |
| v2 | 2024-03-11 | French | Compare |
| v1 | 2024-03-11 | English | Compare |
Showing 1 to 5 of 5